vaccine_midyear

We are excited to be presenting the free online 15th Vaccine Congress: Mid-Year Review, which will take place on 19 April 2021.  We will hear from leading experts on the development and implementation of the newest Covid-19 vaccines.

Speakers will each give a presentation followed by a live panel discussion where you will be able to pose your questions directly to them.

By attending you will gain a unique insight into the latest discoveries as well as a highly valuable opportunity to connect with world experts in the global vaccine community.

Register here

Presenters

Gregory Glenn

Gregory Glenn

President, Research & Development, Novavax Inc, USA

Dr. Glenn is the president of research and development and leads the discovery, clinical, and regulatory teams. He has spent 28 years in the design and development of vaccines, vaccine delivery, and adjuvants.

View full bio

Hanneke Schuitemaker

Hanneke Schuitemaker

Global Head of Viral Vaccine Discovery and Translational Medicine at Johnson & Johnson's Janssen Vaccines & Prevention, The Netherlands

Hanneke Schuitemaker, Ph.D., is the Head of Viral Vaccine Discovery and Translational Medicine and Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention B.V. She has been in these roles since 2010 and oversees the early development of Janssen’s viral vaccine programs including investigational vaccine candidates for HIV, respiratory syncytial virus (RSV), Ebola, Zika, and COVID-19. In addition, she is a Professor of Virology at the Amsterdam University Medical Center.

View full bio

Brian J. Ward

Brian J. Ward

Medical Officer, Medicago, USA

Dr. Brian Ward is passionate about science and innovation. He has active research interests in RNA viruses, vaccine development and international health supported by Canadian and international funding agencies as well as private foundations and industry.

View full bio

Moderator and Conference Chair

Gregory A. Poland

Gregory A. Poland

Editor in Chief, Vaccine and Mayo Clinic, USA

The Vaccine Research Group uses immunological testing, including serology, cell-mediated immunity, cell culture and cytokine assays; polymerase chain reaction (PCR) techniques and HLA typing for immunogenetic studies; and high-throughput assays, such as next-generation sequencing, transcriptomics, mass spectrometry and proteomic analysis.

View full bio

Programme

Monday, 19 April 2021

13:30-13:45 GMT                       Introduction, Gregory A. Poland, Editor in Chief, Vaccine and Mayo Clinic, USA
13:45-14:45 GMT                                                                                   Hanneke Schuitemaker, Global Head of Viral Vaccine Discovery and Translational Medicine at Johnson & Johnson's Janssen Vaccines & Prevention, The Netherlands
14:15-14:45 GMT Brian J. Ward, Medical Officer, Medicago, USA
14:45-15:15 GMT                  Gregory Glenn, President, Research & Development, Novavax Inc, USA
15:15-16:00 GMT   Live panel discussion with Q&A with all speakers